-
-
-
-
-
-
-
OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/25: Retailers Express, Nordstrom Gain Following Earnings; Verrica Pharma Sinks on FDA CRL (more...)
-
-
-
-
-
-
-
OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue
-
-
-
-
-
-
-
OraSure Technologies (OSUR) Reports InteliSwab COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
-
-
-
-
-
-
-
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus
-
-
-
-
-
-
-
U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection
-
-
-
-
-
-
-
OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response
-
922,461 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All